Welcome to our dedicated page for Horizon Techn news (Ticker: HRZN), a resource for investors and traders seeking the latest updates and insights on Horizon Techn stock.
Horizon Technology Finance Corporation (NASDAQ: HRZN) generates a steady flow of news as a specialty finance company and business development company focused on secured lending to growth-oriented businesses. News coverage for HRZN often centers on its lending activity in the technology, life science, healthcare information and services, and sustainability industries, as well as developments in its capital structure and corporate strategy.
Investors following HRZN news can expect regular updates on quarterly and annual financial results, including net investment income, portfolio yields, net asset value per share and portfolio composition. Earnings releases are typically accompanied by management commentary on originations, loan prepayments, credit quality and liquidity, giving insight into how Horizon’s secured loan and warrant portfolio is evolving over time.
Another key stream of Horizon news involves distributions and dividend policy. The company frequently announces monthly cash distributions, with details on ex-dividend dates, record dates and payment dates, and provides context on how its board of directors evaluates taxable income, spillover income and long-term outlook when setting distribution levels. These announcements are often paired with information about the company’s Dividend Reinvestment Plan for shareholders who choose to reinvest distributions.
HRZN news also covers capital markets and financing transactions, such as offerings of public notes, convertible notes and amendments to credit facilities. Press releases and related SEC filings describe new note issuances, interest rates, maturities, redemption terms and intended uses of proceeds, including repayment of existing indebtedness and general corporate purposes.
In addition, Horizon’s disclosures include updates on strategic transactions, notably the announced merger agreement under which Monroe Capital Corporation would merge with and into Horizon, subject to approvals and closing conditions. Investors can monitor this news stream for progress on the merger, related regulatory steps and any changes to the expected structure. For a comprehensive view of HRZN-related developments, this news page aggregates company press releases and market-moving announcements in one place.
Horizon Technology Finance (NASDAQ: HRZN) will release financial results for the quarter ended March 31, 2026 on Tuesday, May 5, 2026 after market close. A conference call to discuss results is scheduled for Wednesday, May 6, 2026 at 9:00 a.m. ET.
The call will feature remarks by Mike Balkin, Paul Seitz, and Dan Trolio. Dial-in numbers and a live listen-only webcast at the company website will be available; an online archive of the webcast will be accessible for 30 days.
Horizon Technology Finance (NASDAQ: HRZN) provided a delayed-draw senior credit facility of up to $25 million to Stellar Cyber on April 16, 2026 to support continued growth. The financing targets acceleration of Stellar Cyber's AI-native, unified security operations platform development and go-to-market expansion.
Stellar Cyber offers 500+ integrations and, through MSSP partners, supports over 14,000 organizations in 50+ countries. The company is backed by Highland Capital Partners, Susquehanna Ventures and Valley Capital Partners.
Horizon Technology Finance (NASDAQ: HRZN) closed its merger with Monroe Capital Corporation (NASDAQ: MRCC) on April 14, 2026, creating a combined externally managed company with approximately $471.7 million of pro forma net assets and $141.1 million in cash.
The deal issued 20,370,693 shares to MRCC holders (0.9402 exchange ratio), resulting in a 70.14% legacy Horizon / 29.86% former MRCC ownership split. Management announced fee waivers, supplemental distributions consideration, and a $10 million repurchase program with NAV-based trading limits.
Horizon Technology Finance (NASDAQ: HRZN) provided a $40 million loan facility to Hyperfine (NASDAQ: HYPR), with $15 million funded at closing and up to $25 million available to support future commercial growth. The financing targets expansion of Hyperfine's FDA-cleared Swoop® point-of-care MR brain imaging system across hospitals and offices.
The facility is presented as supporting Hyperfine's commercial scale-up, a second-generation device rollout, and broader adoption of portable neuroimaging in acute and chronic care settings.
Horizon Technology Finance (NASDAQ: HRZN) and CR Financial Holdings formed a $100 million joint venture to provide growth capital financing to U.S.-based small- and micro-cap public companies.
The JV will target secured loans in the $5–25 million range, use warehouse credit facilities to leverage capital, and be governed by equal representation on a four-person board and investment committee. The venture expects support from Monroe Capital, which had approximately $24 billion AUM as of January 1, 2026.
Horizon Technology Finance (NASDAQ: HRZN) announced the HRZN Board intends to use $27.6 million of undistributed taxable earnings as of December 31, 2025 to supplement regular monthly distributions to combined-company stockholders for two quarters after the closing of the pending merger with Monroe Capital Corporation.
The Board anticipates supplemental distributions for the first post-close quarter of at least $0.02 to $0.04 per share per month, subject to closing, Board declaration, asset coverage, financing covenants, liquidity and market conditions. MRCC separately intends a $13.0 million supplemental pre-merger distribution (about $0.61 per share), contingent on stockholder approval and closing conditions. HRZN’s special meeting is scheduled for March 13, 2026.
Horizon Technology Finance (NASDAQ: HRZN) declared monthly cash distributions of $0.06 per share payable in April, May and June 2026, totaling $0.18 per share. Payments have ex-dividend/record and payment dates in March–May 2026, with payments in April–June 2026.
The Board bases distributions on results, spillover income and outlook, and notes taxable income for distributions will be finalized after year-end. Horizon offers a Dividend Reinvestment Plan (DRIP) and may satisfy DRIP shares via new-issue or open-market purchases.
Horizon Technology Finance (NASDAQ: HRZN) reported Q4 2025 net investment income (NII) of $8.3M ($0.18/share) and NAV of $318.5M ($6.98/share) as of December 31, 2025. Annualized debt portfolio yield was 14.3% for Q4 and 15.8% for full-year 2025.
The Company ended 2025 with a total portfolio of $647.2M, committed backlog of $154M, cash of $142.7M, credit facility capacity of $329.0M, and undistributed spillover income of $0.65/share. The Board declared monthly distributions of $0.06/share for April–June 2026 and continues progress toward the anticipated merger with MRCC.
Horizon Technology Finance (NASDAQ: HRZN) will release fourth-quarter 2025 financial results for the period ended December 31, 2025 on March 3, 2026 after market close. A conference call to discuss results is scheduled for March 4, 2026 at 9:00 a.m. ET.
Executives participating include Mike Balkin (CEO), Paul Seitz (SVP & CIO), and Dan Trolio (EVP & CFO). The call is accessible by phone and via a live listen-only webcast on the company website; an online archive will be available for 30 days.
Horizon Technology Finance (NASDAQ: HRZN) and Monroe Capital closed an initial $40 million senior credit facility for Ossio Inc., with an additional $10 million available to support future growth. The financing aims to accelerate OSSIO’s global expansion of its metal-free OSSIOfiber bone regeneration technology, with development and manufacturing in Caesarea, Israel, and commercial operations in Palmetto, FL.
This growth capital positions OSSIO to scale commercialization while Horizon and Monroe provide strategic healthcare and Israeli technology ecosystem expertise.